Viatris publishes sustainability report
Viatris has released its 2022 Sustainability Report showcasing its commitment, impact and progress on building sustainable access to medicine as it continues to make a positive difference across key areas, including Access and Global Health, Our People, the Environment and the Community.
“At Viatris, access is fundamental to our mission of empowering people worldwide to live healthier at every stage of life," said Scott Smith, CEO at Viatris. "It begins with our ability to sustainably deliver high-quality medicines and health solutions at scale to people, regardless of geography or circumstance. Our commitment is both practical and aspirational and goes beyond developing, making and distributing medicines. We also work with partners to help support healthy communities, a healthy environment and resilient healthcare systems. The passion and dedication of our global workforce is remarkable and clearly on display in this report, which highlights the progress we are making to build more sustainable access to medicine across the globe."
[Read more: Retailers ramp up initiatives to drive equity, diversity and sustainability]
The following are some highlights of Viatris' work and initiatives across its multiple areas of impact in 2022:
Access and Global Health
- Supplied medicines to approximately 1 billion patients globally;
- Provided treatments for approximately 8 million people living with HIV/AIDS, including almost 600,000 children;
- Provided >250 medicines on the World Health Organization Essential Medicines List and 62 products on the WHO Pre-Qualification List; and
- Promoted and strengthened healthcare professional education and training to build more resilient healthcare systems and address the burden of non-communicable diseases, which account for nearly 75% of global deaths annually. More than 300 million patients were impacted by Viatris' outreach to healthcare professionals in 2022;
Our People
- Conducted our first global Viatris Voice Survey with a participation rate of 89%. The baseline survey marked a milestone in our commitment to engage colleagues by listening to their perspectives on overall engagement, diversity, equity and inclusion; health and well-being; transformation and change; and
- Named one of Forbes' World's Best Employers for 2022, ranking in the top 10% of the 800 employers who made the list.
The Environment
- Committed to reducing absolute scope 1 and 2 greenhouse gas emissions by 42% by 2030 from a 2020 base year and further, to reducing absolute Scope 3 greenhouse gas emissions covering purchased goods and services, capital goods, fuel and energy-related activities and upstream transportation and distribution 25% within the same timeframe;
- Viatris received validation and approval of Viatris' scope 1, 2 and 3 greenhouse gas emissions reduction targets from the Science Based Targets initiative. The SBTi classified Viatris' scope 1 and 2 target ambition and has determined that it is in line with the 1.5°C trajectory;
- Performed five water risk assessments—four in facilities in India and one in Turkey; and
- Increased the number of zero-waste landfill locations to a total of 16.
[Read more: Preserving Health, Protecting the Planet: the Path Toward Sustainable Blister Packs]
The Community
- Donated more than 450 million doses of medicines through our partners around the world and provided a total of $1 million to aid in supporting access to health care, food security and water stewardship to four organizations: Direct Relief, World Central Kitchen, WaterAid and World Food Program USA, partner of the United Nations World Food Programme; and
- Supported communities across the globe, including helping to evacuate and relocate people at the onset of the conflict in Ukraine and provided funds, medical donations and supplies to communities devastated by the earthquakes in parts of Turkey and Syria in February 2023.
"We understand our conduct and actions affect the stakeholders and communities we serve," said Lara Ramsburg, head of corporate affairs of Viatris. "We are proud to continue our work as a trusted partner of key stakeholders as we help to close gaps to equal access to care, build more resilient healthcare systems, uphold a reliable global supply of medicines, curb climate change and protect the environment."
Click here to view the 2022 Sustainability Report.